Which factors influence skeletal metastases of breast cancer?
Biersack, H.J.; Frommhold, H.; Breuel, H.P.; Winkler, C.
Medizinische Klinik 75(18): 663-664
1980
ISSN/ISBN: 0025-8458 PMID: 6252426 Document Number: 162264
Document emailed within 1 workday
Related Documents
Mandolini, G.; Falchi, A.M.; De Maria, D.; Ceresatto, E.; Roli, F.; Santantonio, M. 1980: Treatment results with skeletal metastases of breast cancer from 1972 to 1978 La Radiologia Medica 66(1-2): 77-78Krinitsyna, N.N.; Mikhaĭlova, L.V.; Neĭshtadt, E.L.; Gremilov, V.A.; Dymarskiĭ, L.Iu. 1981: Changes in the primary focus and regional metastases of breast cancer under the influence of concentrated preoperative irradiation Voprosy Onkologii 27(1): 32-36
Zedeler, K.; Keiding, N.; Kamby, C. 1994: The significance of prognostic factors on the occurrence of metastases from breast cancer to various localizations Ugeskrift for Laeger 156(1): 42-47
Rosen, L.S.; Gordon, D.; Kaminski, M.; Howell, A.; Belch, A.; Mackey, J.; Apffelstaedt, J.; Hussein, M.; Coleman, R.E.; Reitsma, D.J.; Seaman, J.J.; Chen, B.L.; Ambros, Y. 2001: Zoledronic acid versus pamidronate in the treatment of skeletal metastases in patients with breast cancer or osteolytic lesions of multiple myeloma: a phase III, double-blind, comparative trial Cancer Journal 7(5): 377-387
Domènech, A.; Benítez, A.; Bajén, M.T.; Ricart, Y.; Rodríguez-Gasén, A.; Palacín, J.A.; Català, I.; Gil, M.; Pernas, S.; García, A.; Martín-Comín, J. 2009: What are the preoperative factors that can determine the presence of metastases in other axillary nodes in breast cancer when the sentinel node is positive? Quarterly Journal of Nuclear Medicine and Molecular Imaging: Official Publication of the Italian Association of Nuclear Medicine and the International Association of Radiopharmacology and Section of the Society Of. 53(4): 422-427
Li, Q.; Xu, B-he.; Zhang, P.; Li, Q.; Yuan, P.; Wang, J-yu.; Luo, Y.; Ma, F.; Fan, Y.; Li, Q. 2013: Clinicopathological features and prognostic factors of breast cancer patients with inguinal lymph node metastases: a report of 17 cases Zhonghua Zhong Liu Za Zhi 35(3): 207-211
Keller, E.T. 2002: The role of osteoclastic activity in prostate cancer skeletal metastases Drugs of Today 38(2): 91-102
Stamatovic, L.; Susnjar, S.; Gavrilovic, D.; Minic, I.; Ursulovic, T.; Dzodic, R. 2018: The influence of breast cancer subtypes on the response to anthracycline neoadjuvant chemotherapy in locally advanced breast cancer patients Journal of Buon: Official Journal of the Balkan Union of Oncology 23(5): 1273-1280
Kashyap, R.; Balasubramanian Harisankar, C.N.; Parmar, M.; Bhattacharya, A.; Singh, B.; Mittal, B.R. 2010: Incidental detection of skeletal metastases from thyroid cancer during myocardial perfusion imaging Hellenic Journal of Nuclear Medicine 13(2): 169-170
Zissimopoulos, A.; Stellos, K.; Matthaios, D.; Petrakis, G.; Parmenopoulou, V.; Babatsikou, F.; Matthaiou, E.; Theodosiadou, E.; Hountis, P.; Koutis, C. 2009: Type i collagen biomarkers in the diagnosis of bone metastases in breast cancer, lung cancer, urinary bladder cancer and prostate cancer. Comparison to CEA, CA 15-3, PSA and bone scintigraphy Journal of Buon: Official Journal of the Balkan Union of Oncology 14(3): 463-472
Rudan, I.; Skorić, T.; Rudan, N. 1994: Breast cancer prognosis. I. Prognostic factors in patients with node-negative (N0) breast cancer Acta Medica Croatica: Casopis Hravatske Akademije Medicinskih Znanosti 48(4-5): 159-163
Rudan, I.; Skorić, T.; Rudan, N. 1994: Breast cancer prognosis. II. Prognostic factors in patients with node-positive (N1-3) breast cancer Acta Medica Croatica: Casopis Hravatske Akademije Medicinskih Znanosti 48(4-5): 165-170
Paterson, A.H. 1987: Bone metastases in breast cancer, prostate cancer and myeloma Bone 8(Suppl 1): S17-S22
Tominaga, T.; Abe, O.; Izuo, M.; Isono, K.; Enomoto, K.; Nishi, M.; Fukami, A.; Muto, T.; Morioka, Y.; Watanabe, H. 1993: Correlations between estrogen receptor and prognostic factors of patients with breast cancer. the Kanto Cooperative Study Group of Adjuvant Chemoendocrine Therapy for Breast Cancer, Japan Gan to Kagaku Ryoho. Cancer and ChemoTherapy 20(14): 2171-2176
Kachanov, I.P. 1979: Breast cancer metastases to the bones Khirurgiia 6: 65-70
Rorive, A.; Collignon, J.; Martin, M.; André, C.; Jerusalem, G.; Coucke, P. 2011: Breast cancer and brain metastases Revue Medicale de Liege 66(5-6): 299-305
Watne, K. 1983: Intracranial metastases in breast cancer Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 103(33): 2234-2236
Sun, X.; Liu, J-Juan.; Wang, Y-Sheng.; Song, X-Rang.; Zhong, W-Xia.; Zhou, C-Chun.; Mu, D-Bin.; Zuo, W-Shu.; Yu, Z-Yong.; Zhou, Z-Bo. 2011: Using intra-operative GeneSearchTM Breast Lymph Node Assay to detect breast cancer metastases in sentinel lymph nodes: results from a single institute in China Chinese Medical Journal 124(7): 973-977
Rahn, A.N.; Mose, S.; Zander-Heinz, A.; Budischewski, K.; Bormeth, S.B.; Adamietz, I.A.; Böttcher, H.D. 1998: Influence of radiotherapy on psychological health in breast cancer patients after breast conserving surgery Anticancer Research 18(3c): 2271-2273
Heimpel, H. 1987: Treatment of bone metastases of breast cancer Deutsche Medizinische Wochenschrift 112(7): 286